Skip to main content
Veterinary Medicines

V.H. + H-120, liofilizatas vištoms

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain V.H., Live

Product identification

Medicine name:
V.H. + H-120, liofilizatas vištoms
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain V.H., Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use
  • Ocular use
  • Coarse spray
  • Nebulisation use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    3162.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Newcastle disease virus, strain V.H., Live
    1000000.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
  • Ocular use
    • Chicken
      • Meat and offal
        0
        day
  • Coarse spray
    • Chicken
      • Meat and offal
        0
        day
  • Nebulisation use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Abic Polska Sp. z o.o.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/08/1832/001-005
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."